Brief: Faron Pharmaceuticals Gets FDA Fast Track Designation For Bexmarilimab
Aug 26 (Reuters) - Faron Pharmaceuticals Oy FARN.L :
* FDA GRANTS FAST TRACK DESIGNATION FOR BEXMARILIMAB
Source text for Eikon: ID:nWkr46CPLV
Further company coverage: FARN.L
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Faron Pharmaceuticals Oy
See all newsFaron Pharmaceuticals: Faron to Report Final Melanoma Survival Data from the MATINS Study at ESMO 2026
Faron Pharmaceuticals: Composition of Faron Pharmaceutical’s Shareholders’ Nomination Board
Convertible bond amortization payment deferred by mutual agreement with HCM
Issuance of warrants
HOLDING(S) IN COMPANY